TNFAIP2 and esophageal squamous cell carcinoma: The abnormal expression of TNFAIP2 has been identified in various malignant tumors, involved in unlimited proliferation, angiogenesis, and migration, including urothelial cancer, esophageal squamous cell carcinoma, and nasopharyngeal carcinoma (39–42).